Angeles Investment Advisors LLC lowered its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 53.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,537 shares of the company’s stock after selling 4,103 shares during the quarter. […]